Synonyms:Imatinib, 152459-95-5, STI571, Glivec, Imatinib (STI571), sti-571, Imatinib free base, Cgp 57148, N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide, STI 571, UNII-BKJ8M8G5HI, Imatinib Methansulfonate, CGP-57148, 152459-95-5 (free base), BKJ8M8G5HI, 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE, 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide, CHEMBL941, CHEBI:45783, MFCD05662257, NSC743414, 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide, N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide, Imatinib [INN:BAN], 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide, Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, STI, alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide, Imatinib (INN), 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide, Glamox (TN), CCRIS 9076, C29H31N7O, SR-01000763561, NCGC00159456-02, ST1571, ST 1571, imatinib-CD3, 1iep, 1xbb, Gleevec(TM), 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl)-benzamide, 4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide, Imatinib (Gleevec), Imatinib - Gleevec, Imatinib, 21, Imatinib, Free base, alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide, Kinome_3724, 112GI019, Gleevec (TN) (Novartis), cid_5291, SCHEMBL3827, Imatinib-d3(N-methyl-d3), STI-571; IMATINIB, 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide, BIDD:GT0047, GTPL5687, DTXSID3037125, BDBM13530, EX-A063, QCR-269, BCPP000205, CGP057148B, HMS2089D03, HMS3244P06, HMS3244P10, HMS3244P14, HMS3656K04, HMS3715P03, Pharmakon1600-01502276, BCP01542, AC-524, NSC759854, NSC800772, STK617705, VCC905240, ZINC19632618, AKOS000280662, BCP9000775, CCG-101289, CS-0964, DB00619, ES-0058, MCULE-2384256888, NSC 743414, NSC 759854, NSC-743414, NSC-759854, NSC-800772, SB17306, ST-1571, MRF-0000449, NCGC00159456-01, NCGC00159456-03, NCGC00159456-04, NCGC00159456-05
Pubchem:PUBCHEM:5291
Id:5291
Description:nan
